With a proven track record supporting public health crises and the expertise to rapidly scale high-quality oligonucleotide production to meet growing demand for testing reagents, LGC, Biosearch Technologies is prepared to support testing to help slow the spread of COVID-19.
This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers based on genetic signatures for the following:
Oligonucleotide sequences were designed by German Center for Infection Research (DZIF) at Charité. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.